Dr. Manish Singhal
| Dr. Manish Singhal | |
|---|---|
| Born | 12th September 1977 |
| 🏳️ Nationality | Indian |
| 💼 Occupation | Oncologist |
| Known for | Chemotherapy, Targeted Therapy, Intensive Protocol, Immunotherapy, Hormonal Therapy |
| 👩 Spouse(s) | Dr Anika Singhal (Head of Laboratory & Pathology, Apollo Hospitals Noida) |
| 🌐 Website | https://cancerconsultindia.com/ |
Dr. Manish Singhal (Born 12th September 1977) is a senior Indian oncologist renowned for his contributions to the field of cancer. He is also the Founder and Director of Cancer Consult India, an online portal dedicated to patient education and awareness. He serves as the Senior Medical Oncologist at the prestigious Apollo Hospital Delhi & Noida.
Life and Career
His passion for oncology was inspired by his father's illness, who has been a cancer warrior for the past 18 years. This was a major deciding factor for him to pursue oncology as a career. Dr. Manish Singhal completed his MBBS from the Mumbai University in 2002. Later, he pursued his MD in internal medicine from Maharshi Dayanand University, Rohtak and completed it in the first attempt. Determined and focused, Dr. Manish Singhal further went on to complete his Fellowship in Medical Oncology from the prestigious All India Institute of Medical Science (AIIMS) New Delhi and completed it in the first attempt as well. It was his ardent interest in academics and willingness to stay up to date that earned him 'The Best Exam Award' at ESMO (European society of Medical Oncology) Examination 2013 for scoring the top marks globally, making him the first and only Indian to achieve this feat. Later he was awarded as the best doctor for 2014 and 2015 during his tenure at Fortis Hospital Noida with best patient reviews and feedback. He has served as a member on multiple prestigious committees and bodies, including the ISMPO (Indian Society of Medical and Pediatrics Oncology), ICON (Indian Cooperative Oncology Network), NCR (National Capital Region) Oncology Forum. Dr. Manish Singhal has been an honorable member of one of the most prominent organizations including Member of European Society of Medical Oncology (2013), Member of Society of Clinical oncology (2009), Indian Academy of Clinical Medicine (2007), Association of Physicians of India (2007), Delhi Diabetes Forum (2007), Indian Association of Palliative care (2009), Indian Cooperative Oncology Network (2010), and Society of Medical Oncology of India (2012). Dr. Manish Singhal also had the opportunity to hold the first annual symposium for NCR Oncology Forum at India Habitat Center on 2nd and 3rd Sep 2017. He has been instrumental in establishing International Oncology Cancer Centers in Tier 2 cities (Panipat) in an endeavor to provide world class cancer care to the underserved areas. Having over 17 years of extensive experience treating cancer patients, his expertise spans all types of chemotherapy, intensive protocols, immunotherapy, hormonal therapy in addition to dealing with oncological emergencies, including medical care of patients.
Honors & Achievements
- Best Exam Award for ESMO (European society of Medical Oncology) Examination 2013, for scoring highest marks globally.
- Awarded as best doctor for 2014 and 2015 during his tenure at Fortis Hospital Noida.
- Privilege (one among 20 key national figures on lung diseases) of recording lecture on “Small cell carcinoma lung” for the “e-module of pulmonary medicine” endorsed by Diplomate National board (DNB) and NCCP (National College of Chest Physicians)
Projects & Research Contribution
- Ezetimibe as an adjunct to Atorvastatin in patients of Dyslipidemia, from 2004-2006.
- Prognostic Value of Plasma High Sensitivity C - reactive protein in Patients with Acute Myocardial Infarction, from 2006 to 2007.
- Analysis of Peripheral T-Cell Lymphomas: Incidence, Clinical Characteristics, Prognostic Factors, and Treatment Outcomes of 139 cases, from 2007 -2010.
- Quantitative estimation of bcr-abl transcripts, To see molecular remission status in patients of Chronic Myeloid Leukemia, from 2008-2010.
- Iniparib in TNBC – multinational phase 3 study, from 2010-2012.
- TDM-1 in breast cancer – post taxane and trastuzumab, from 2016.
- Ancers-1 – Canscript in solid organ malignancies from 2017.
- Povidone Iodine RCT (multinational) for chemotherapy-induced paronychia, from 2017.
- Zytiga – in prostate cancer – phase IV, from 2016-2017.
- Nintedanib in NSCLC – phase IV, from 2017.
- IGF-1 antibody in breast cancer - Lily sponsored study, from 2016-2017.
References
[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12][13][14][15][16]
- ↑ Dr. Singhal, Manish (2005). "Ezetimibe as an adjunct to Atorvastatin in patients of Dyslipidemia". Indian Heart Journal. 57:562-564 (Abstract 469).
- ↑ Dr. Singhal, Manish. "Prognostic Value of Plasma High Sensitivity C-Reactive Protein in Patients with Acute MI". Indian Heart Journal. 2006; 58:394-410. (Abstract 79).
- ↑ "Efficacy of oxaliplatin, 5 FU and gemcitabine in advanced pancreato-biliary cancer". J Clin Oncol. 25, No. 18S (June 20 Supplement), 2007: 15182.
- ↑ "Primary myositis coinciding with vincristine-induced neuropathic pain and urinary retention in rhabdomyosarcoma: an unusual occurrence". J Pediatr Hematol Oncol. 2008 Nov;30(11):869.
- ↑ "Isolated ovarian relapse in a 68 year old female with acute lymphoblastic leukemia – an under reported occurrence". As Diagnosis in Oncology in J Clin Oncol Doi/10.1200/Journal of Clinical Oncology. 2009.24.1398.
- ↑ "Heart As The Site of First Relapse in Diffuse Large B-Cell Lymphoma". Letter to Editor in Indian Journal of Cancer. 2010; 47: 220-222.
- ↑ "T-cell Prolymphocytic leukemia detected in a patient of breast cancer at the time of recurrence". Cases Journal. 2010, 3:4 (BM Central).
- ↑ Singhal, M. K.; Sengar, M.; Nair, R. (2016). "Summary of the published Indian data on chronic myeloid leukemia". South Asian J Cancer. 2016; 5(3): 162 (3): 162–165. doi:10.4103/2278-330X.187593. PMC 4991141. PMID 27606306.
- ↑ Murthy, V.; Calcuttawala, A.; Chadha, K.; d'Cruz, A.; Krishnamurthy, A.; Mallick, I.; Nair, S.; Teni, T.; Pawar, S.; Talapatra, K.; Patil, A.; Bhatt, A.; Chatterjee, S.; Swain, M.; Narayanan, P.; Ghadyalpatil, N.; Singhal, M.; Kuriakose, M.; Prabhash, K.; Agarwal, J.; Parikh, P. (2017). "Human papillomavirus in head and neck cancer in India: Current status and consensus recommend". South Asian J Cancer. 2017; 6(3): 93–98. (3): 93–98. doi:10.4103/sajc.sajc_96_17. PMC 5615888. PMID 28975111.
- ↑ "Dr. Manish Singhal - Senior Medical Oncologist". Sehat.
- ↑ "Dr. Manish Singhal - Senior Medical Oncologist at Apollo Hospitals". Apollo247.
- ↑ "Dr. Manish Singhal - Senior Medical Oncologist". Credihealth.
- ↑ "Dr. Manish Singhal - Senior Medical Oncologist". Onco.
- ↑ Singhal, Dr. Manish. "Dr. Manish Singhal - Senior Medical Oncologist". Vaidam.
- ↑ "Dr. Manish Singhal - Senior Medical Oncologist". Lybrate.
- ↑ Singhal, Dr. Manish. "Dr. Manish Singhal - Senior Medical Oncologist". Practo.
External Links:
This article "Manish Kumar Singhal" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Manish Kumar Singhal. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
